Form 8-K - Current report:
SEC Accession No. 0001104659-19-015410
Filing Date
2019-03-18
Accepted
2019-03-18 08:31:12
Documents
3
Period of Report
2019-03-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-6684_18k.htm 8-K 25167
2 EX-99.1 a19-6684_1ex99d1.htm EX-99.1 19236
3 GRAPHIC g66841mmi001.jpg GRAPHIC 2471
  Complete submission text file 0001104659-19-015410.txt   49157
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 19686913
SIC: 2834 Pharmaceutical Preparations